{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:47:43Z","timestamp":1792666063502,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clnu.2024.05.025","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T11:33:33Z","timestamp":1716032013000},"page":"1618-1625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis"],"prefix":"10.1016","volume":"43","author":[{"given":"Junfang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4095-8427","authenticated-orcid":false,"given":"Yu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.05.025_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.clnu.2024.05.025_bib2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clnu.2024.05.025_bib3","article-title":"Long-term survival of patients with metastatic non-small-cell lung cancer over five decades","volume":"2021","author":"Bar","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clnu.2024.05.025_bib4","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3312302","article-title":"Lung cancer screening: the hidden public health emergency","volume":"33","author":"Stone","year":"2023","journal-title":"Public Health Res Pract"},{"key":"10.1016\/j.clnu.2024.05.025_bib5","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer cachexia: definition, staging, and emerging treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clnu.2024.05.025_bib6","article-title":"Diagnosis and prevalence of cachexia in Asians: a scoping review","volume":"119","author":"Ueshima","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2024.05.025_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.21037\/tlcr-22-561","article-title":"The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review","volume":"12","author":"Morita-Tanaka","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.clnu.2024.05.025_bib8","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3390\/ijms22062890","article-title":"Cachexia as evidence of the mechanisms of resistance and tolerance during the evolution of cancer disease","volume":"22","author":"Maccio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnu.2024.05.025_bib9","first-page":"3473","article-title":"Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib10","first-page":"1699","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijrobp.2018.04.053","article-title":"Incidence and impact of pretreatment tumor cavitation on survival outcomes of stage III squamous cell lung cancer patients treated with radical concurrent chemoradiation therapy","volume":"101","author":"Topkan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clnu.2024.05.025_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14737159.2019.1579644","article-title":"Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer","volume":"19","author":"Bozkaya","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.clnu.2024.05.025_bib13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.clnu.2019.08.003","article-title":"Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients","volume":"39","author":"Jouinot","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2024.05.025_bib14","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.21037\/tlcr-21-460","article-title":"Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors: results from a prospective, observational study","volume":"10","author":"Rounis","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.clnu.2024.05.025_bib15","first-page":"1633","article-title":"Impact of weight loss on treatment with PD-1\/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer","volume":"30","author":"Miyawaki","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1950411","article-title":"Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study","volume":"10","author":"Morimoto","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.clnu.2024.05.025_bib17","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.3390\/cancers14215405","article-title":"Cancer cachexia among patients with advanced non-small-cell lung cancer on immunotherapy: an observational study with exploratory gut microbiota analysis","volume":"14","author":"Hakozaki","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.clnu.2024.05.025_bib18","doi-asserted-by":"crossref","first-page":"10563","DOI":"10.1002\/cam4.5791","article-title":"Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: a prospective cohort study","volume":"12","author":"Sheikh","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.clnu.2024.05.025_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2024.05.025_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2024.05.025_bib21","author":"Wells"},{"key":"10.1016\/j.clnu.2024.05.025_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.clnu.2024.05.025_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2024.05.025_bib24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/1759-7714.14421","article-title":"Impact of losing adipose tissue on outcomes from PD-1\/PD-L1 inhibitor monotherapy in non-small cell lung cancer","volume":"13","author":"Nishioka","year":"2022","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/mco.2022.2524","article-title":"Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer","volume":"16","author":"Fujii","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.clnu.2024.05.025_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-021-02997-2","article-title":"Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab","volume":"71","author":"Jo","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clnu.2024.05.025_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/1759-7714.14881","article-title":"Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors","volume":"14","author":"Matsuo","year":"2023","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/COC.0000000000001053","article-title":"Impact of pretreatment weight loss on radiotherapy utilization and clinical outcomes in non-small cell lung cancer","volume":"47","author":"Alvarez","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clnu.2024.05.025_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43866-5","article-title":"Male sex and pretreatment weight loss are associated with poor outcome in patients with advanced non-small cell lung cancer treated with immunotherapy: a retrospective study","volume":"13","author":"Jin","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2024.05.025_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/IJGM.S382577","article-title":"Overweight and obesity are associated with poorer survival among patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy","volume":"16","author":"Sutandyo","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.clnu.2024.05.025_bib31","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/bjs\/znad239","article-title":"The prognostic impact of pre-treatment cachexia in resectional surgery for oesophagogastric cancer: a meta-analysis and meta-regression","volume":"110","author":"Brown","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnu.2024.05.025_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4137\/CMO.S30891","article-title":"Cachexia index in advanced non-small-cell lung cancer patients","volume":"9","author":"Jafri","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.clnu.2024.05.025_bib33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/01635581.2020.1769691","article-title":"The role of a cachexia grading system in patients with non-small cell lung cancer treated with immunotherapy: implications for survival","volume":"73","author":"Turcott","year":"2021","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clnu.2024.05.025_bib34","first-page":"16","volume":"vol. 45","author":"Gaafer","year":"2021"},{"key":"10.1016\/j.clnu.2024.05.025_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14656566.2023.2194489","article-title":"Current advancements in pharmacotherapy for cancer cachexia","volume":"24","author":"da Fonseca","year":"2023","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.clnu.2024.05.025_bib36","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/jcsm.13333","article-title":"Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer","volume":"14","author":"Tao","year":"2023","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2024.05.025_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.athoracsur.2019.04.090","article-title":"Computed tomography-assessed skeletal muscle mass as a predictor of outcomes in lung cancer surgery","volume":"108","author":"Nishimura","year":"2019","journal-title":"Ann Thorac Surg"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:07:57Z","timestamp":1778677677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0261561424001717"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.025","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}